About Genospace
Genospace is a company based in Boston (United States) founded in 2011 was acquired by Sarah Cannon in January 2017.. Genospace has raised $5 million across 4 funding rounds from investors including Thomson Reuters, NIH and HHS. The company has 22 employees as of December 31, 2017. Genospace offers products and services including Clinical Trial Matching, EMR-to-EDC Integration, and Study Feasibility. Genospace operates in a competitive market with competitors including Modernizing Medicine, Guardant Health, Natera, Practice Fusion and Flatiron Health, among others.
- Headquarter Boston, United States
- Employees 22 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Genospace Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5 M (USD)
in 4 rounds
-
Latest Funding Round
$137 K (USD), Grant
Sep 23, 2014
-
Investors
Thomson Reuters
& 3 more
-
Employee Count
22
as on Dec 31, 2017
-
Acquired by
Sarah Cannon
(Jan 12, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genospace
Genospace offers a comprehensive portfolio of products and services, including Clinical Trial Matching, EMR-to-EDC Integration, and Study Feasibility. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Matches patients to oncology trials using clinical-genomic data.
Transfers EMR data to trial databases for efficient research coordination.
Assesses site enrollment potential based on historical data and metrics.
Unlock access to complete
Funding Insights of Genospace
Genospace has successfully raised a total of $5M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $137 thousand completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $137,000
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2014 | Amount | Grant - Genospace | Valuation |
investors |
|
| Sep, 2014 | Amount | Grant - Genospace | Valuation |
investors |
|
| Aug, 2014 | Amount | Series A - Genospace | Valuation | Thomson Reuters |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Genospace
Genospace has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Thomson Reuters, NIH and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Cloud-based legal management and data services are provided for businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Genospace
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Genospace
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genospace Comparisons
Competitors of Genospace
Genospace operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Modernizing Medicine, Guardant Health, Natera, Practice Fusion and Flatiron Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-driven EMR and practice management software is delivered for clinics.
|
|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Cloud-based EHR system is provided for physicians' practices.
|
|
| domain | founded_year | HQ Location |
Cloud-based oncology management tools are provided for cancer care providers.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Genospace
When was Genospace founded?
Genospace was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Where is Genospace located?
Genospace is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Genospace a funded company?
Genospace is a funded company, having raised a total of $5M across 4 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on May 08, 2014.
How many employees does Genospace have?
As of Dec 31, 2017, the latest employee count at Genospace is 22.
What does Genospace do?
Genospace was founded in 2011 and is headquartered in Boston, United States. Operations focus on the genomic medicine sector, where cloud-based software is developed for precision medicine applications. Services include custom solutions for pathology laboratories, healthcare providers, research institutions, clinical development teams, and patients. Genomic data is analyzed to support therapeutic decision-making across research, lab medicine, and clinical care settings.
Who are the top competitors of Genospace?
Genospace's top competitors include Modernizing Medicine, Guardant Health and Flatiron Health.
What products or services does Genospace offer?
Genospace offers Clinical Trial Matching, EMR-to-EDC Integration, and Study Feasibility.
Who are Genospace's investors?
Genospace has 4 investors. Key investors include Thomson Reuters, NIH, HHS, and Sarah Cannon.